Sanofi Stock Quote 1SAN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

90.25

Bid

89.00

Ask

91.31

Volume

481

89.92 Day's Range 90.72

84.98 52 Week Range 107.96

Market Cap

113.051B

Previous Close

91.11

Open

90.64

Last Trade

90.25

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

745

Shares Outstanding

1,252,640,466

Dividend Yield

4.17%

PE Ratio

21.17

Earnings Per Share (EPS)

4.31

Revenue

43.07B

Net Profit

5.4B

Sector

Health & Allied Services,nec

Industry

Pharmaceutical Preparations

Website

www.sanofi.com

Headquarters

Paris, Paris, Fra

Founded

1994

Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 91.11 €. Over the last year, Sanofi shares have traded in a share price range of 84.98 € to 107.96 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 114.13 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.17.

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées

Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées Le...

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Tolebrutinib designated Breakthrough Therapy by the FDA for...

Communiqué de presse : Examen accéléré accordé aux États-Unis à deux candidats-vaccins combinés pour la prévention de la grippe et du COVID-19

Communiqué de presse : Examen accéléré accordé aux États-Unis à deux candidats-vaccins combinés pour la prévention de la grippe et du COVID-19 Examen accéléré accordé aux États-Unis à deux...

Press Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US

Press Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US Two combination vaccine candidates for prevention of influenza...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.34	0.378155933711	89.91	92	87.48	1300	90.61067374	DE
4	-1.6	-1.74197060425	91.85	96.28	87.48	886	91.36796929	DE
12	-11.49	-11.293493218	101.74	104.22	87.48	745	94.66112891	DE
26	3.29	3.78334866605	86.96	107.96	86.81	881	96.02889049	DE
52	1.09	1.22252131	89.16	107.96	84.98	846	93.11627232	DE
156	4.57	5.33380018674	85.68	107.96	76.36	971	91.63274323	DE
260	0	0	90.25	107.96	68	1481	87.82933331	DE

1SAN - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?

The current share price of Sanofi is 90.25 €

How many Sanofi shares are in issue?

Sanofi has 1,252,640,466 shares in issue

What is the market cap of Sanofi?

The market capitalisation of Sanofi is EUR 114.13B

What is the 1 year trading range for Sanofi share price?

Sanofi has traded in the range of 84.98 € to 107.96 € during the past year

What is the PE ratio of Sanofi?

The price to earnings ratio of Sanofi is 21.17

What is the cash to sales ratio of Sanofi?

The cash to sales ratio of Sanofi is 2.65

What is the reporting currency for Sanofi?

Sanofi reports financial results in EUR

What is the latest annual turnover for Sanofi?

The latest annual turnover of Sanofi is EUR 43.07B

What is the latest annual profit for Sanofi?

The latest annual profit of Sanofi is EUR 5.4B

What is the registered address of Sanofi?

The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017

What is the Sanofi website address?

The website address for Sanofi is www.sanofi.com

Which industry sector does Sanofi operate in?

Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WFTC26Finanzatech Spa	0.025 € (26.26%)	40
WART28DeodatoGallery SpA	0.0558 € (24.00%)	27.4k
WFAE25Fae Technology	0.50 € (16.23%)	20
WSGC28SG Company SpA	0.0294 € (13.51%)	1,000
WPOZ27Pozzi Milano Spa	0.102 € (13.33%)	14.05k
WPSQ26Pasquarelli Auto SpA	0.0109 € (-44.10%)	923
1CDECoeur Mining Inc	5.51 € (-20.63%)	500
1WCHWacker Chemie AG	67.50 € (-18.28%)	218
WTFINTrevi Finanziaria Industriale Spa	1.011 € (-17.54%)	2.42k
EPHEPH SpA	0.1002 € (-16.50%)	6.72k
TITTelecom Italia SpA	0.243 € (-3.19%)	370.41M
ISPIntesa Sanpaolo Spa	3.841 € (-0.31%)	137.21M
SPMSaipem Spa	2.484 € (-6.02%)	64.72M
TITRTelecom Italia	0.2813 € (-3.10%)	47.53M
ENELEnel Spa	6.804 € (0.04%)	42.28M